| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.075 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |